Publication date: Sep 06, 2019
Precision medicine has become a novel and rising concept, which depends much on the identification of individual genomic signatures for different patients. The cancer cell lines could reflect the “omic” diversity of primary tumors, based on which many works have been carried out to study the cancer biology and drug discovery both in experimental and computational aspects. In this work, we presented a novel method to utilize weighted graph regularized matrix factorization (WGRMF) for inferring anticancer drug response in cell lines. We constructed a p-nearest neighbor graph to sparsify drug similarity matrix and cell line similarity matrix, respectively. Using the sparsified matrices in the graph regularization terms, we performed matrix factorization to generate the latent matrices for drug and cell line. The graph regularization terms including neighbor information could help to exclude the noisy ingredient and improve the prediction accuracy. The 10-fold cross-validation was implemented, and the Pearson correlation coefficient (PCC), root-mean-square error (RMSE), PCCsr, and RMSEsr averaged over all drugs were calculated to evaluate the performance of WGRMF. The results on the Genomics of Drug Sensitivity in Cancer (GDSC) dataset are 0.64 +/- 0.16, 1.37 +/- 0.35, 0.73 +/- 0.14, and 1.71 +/- 0.44 for PCC, RMSE, PCCsr, and RMSEsr in turn. And for the Cancer Cell Line Encyclopedia (CCLE) dataset, WGRMF got results of 0.72 +/- 0.09, 0.56 +/- 0.19, 0.79 +/- 0.07, and 0.69 +/- 0.19, respectively. The results showed the superiority of WGRMF compared with previous methods. Besides, based on the prediction results using the GDSC dataset, three types of case studies were carried out. The results from both cross-validation and case studies have shown the effectiveness of WGRMF on the prediction of drug response in cell lines.
Open Access PDF
Guan, N.N., Zhao, Y., Wang, C.C., Li, J.Q., Chen, X., and Piao, X. Anticancer Drug Response Prediction in Cell Lines Using Weighted Graph Regularized Matrix Factorization. 05384. 2019 Mol Ther Nucleic Acids (17):
|drug||DRUGBANK||Factor IX Complex (Human)|
- A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
- Looking beyond the hype: Applied AI and machine learning in translational medicine.
- Expression levels of therapeutic targets as indicators of sensitivity to targeted therapeutics.